Retroviruses — HIV and HTLV
The retroviruses ★★★
Enveloped viruses possessing an RNA genome, which replicate via a DNA intermediate. The two enzymes that make this possible are reverse transcriptase and integrase.
⭐ Common characteristics — four
- Spherical enveloped virion, 80–120 nm
- Genome: TWO COPIES of linear +ssRNA, covalently linked, with gag, pol and env genes and also regulatory genes
- Contain REVERSE TRANSCRIPTASE
- Reverse transcribe the RNA genome into DNA and INTEGRATE it into the host genome as a PROVIRUS
| Group | Disease |
|---|---|
| HIV | AIDS |
| HTLV-1 / HTLV-2 | Adult T-cell leukaemia · hairy cell leukaemia |
- Define Retroviridae. → Enveloped viruses with an RNA genome that replicate via a DNA intermediate, using reverse transcriptase and integrase
- Give the four common characteristics. → Spherical enveloped virion 80–120 nm · two covalently linked copies of linear +ssRNA with gag, pol, env and regulatory genes · contain reverse transcriptase · reverse transcribe RNA to DNA and integrate as a provirus
- Name the two groups and their diseases. → HIV → AIDS; HTLV-1/2 → adult T-cell leukaemia and hairy cell leukaemia
HIV structure ★★★
The Nobel Prize in Physiology or Medicine 2008 went to Françoise Barré-Sinoussi and Luc Montagnier for their discovery of the human immunodeficiency virus.
| Layer | Content |
|---|---|
| Shape and size | Spherical, enveloped, 100 nm in diameter |
| Envelope | gp120 and gp41 |
| Capsid | p24 |
| Core | Two identical copies of +ssRNA (DIPLOID +ssRNA) · reverse transcriptase · integrase |
| Genome | Genes |
|---|---|
| 3 structural genes | env, pol, gag |
| 6 non-structural genes | tat, rev, nef, vif, vpr, vpu |
| Detail | |
|---|---|
| Cultivation | Cell culture in cells expressing CD4 only — T cells, macrophages. Animal model: primates |
| Resistance | WEAK. Inactivated by 70% ethanol and 0.3% hydrogen peroxide; inactivated at 56 °C for 30 minutes; survives 7 days at room temperature |
- Describe HIV structure. → Spherical, enveloped, 100 nm; envelope gp120 and gp41, capsid p24, core with two identical copies of +ssRNA plus reverse transcriptase and integrase
- Name the genes. → Three structural — env, pol, gag; six non-structural — tat, rev, nef, vif, vpr, vpu
- How is it cultured? → Only in CD4-expressing cells such as T cells and macrophages; primates as the animal model
- What is its resistance? → Weak — inactivated by 70% ethanol, 0.3% H₂O₂, and 56 °C for 30 min; survives 7 days at room temperature
The HIV life cycle ★★★
| Step | Detail |
|---|---|
| 1 · Binding | Infection begins with the interaction of gp120 with the CD4 MOLECULE on the surface of the target cell — of profound significance for therapy. Then a conformational change in the gp120/gp41 complex is induced by interaction of gp120 with the CHEMOKINE CO-RECEPTORS CCR5 or CXCR4 |
| 2 · Penetration | The virus FUSES with the cell and the viral core with its RNA is internalised |
| 3 · Uncoating | |
| 4 · Reverse transcription | From the RNA genome of HIV to DNA |
| 5 · Integration | The virus's own INTEGRASE inserts the viral DNA into the host cell's DNA. The integrated retroviral DNA is called a PROVIRUS |
| 6 · Transcription | The integrated proviral DNA is transcribed by HOST RNA POLYMERASE II into multiple copies of viral RNA, coding for viral proteins and enzymes and later packaged as new viruses |
| 7 · Translation | Nine genes: structural proteins (viral envelope, core protein, reverse transcriptase) and non-structural regulatory proteins. Viral RNA is translated into a LONG POLYPEPTIDE CHAIN, which VIRAL PROTEASE cuts into its individual enzyme components |
| 8 · Envelope processing | Newly synthesised gp160 localises to the Golgi apparatus, where it is cleaved into gp120 and gp41 by the host protease FURIN |
| 9 · Assembly | At the cell membrane |
| 10 · Extrusion | Budding |
The flow of information is RNA → DNA → RNA, by reverse transcriptase (viral) → integrase (viral) → host RNA polymerase II (host).
The deck's note on step 1 — of profound significance for therapy — applies to the whole cycle. Every step where the virus uses its own enzyme is a point where a drug can act without harming the patient. That is Unit 18 §6's argument about why antivirals are hard: HIV is the exception because it brings three enzymes of its own.
Reverse transcriptase (step 4) → AZT, ddI (nucleoside RT inhibitors) and nevirapine (non-nucleoside).
Viral protease (step 7) → saquinavir, indinavir, ritonavir.
Integrase (step 5) and fusion (steps 1–2) → the later drug classes.
HAART combines two nucleoside RT inhibitors with one protease inhibitor — attacking two different steps at once, so a virus resistant to one is still stopped by the other. That is the same principle as multi-drug tuberculosis therapy in Unit 13.
Notice also what is not targetable: step 5 makes the provirus a permanent part of the host chromosome. No drug removes it. That is why HAART “just controls the progress of AIDS”, in the deck's own words, and why treatment is lifelong.
- What does gp120 bind, and what is the co-receptor? → CD4; then the chemokine receptors CCR5 or CXCR4
- What is a provirus? → Retroviral DNA integrated into the host cell DNA by viral integrase
- Which enzymes are viral and which host? → Viral: reverse transcriptase, integrase, protease. Host: RNA polymerase II for transcription, and furin for cleaving gp160 into gp120 and gp41
- What does viral protease do? → Cuts the long translated polypeptide chain into individual enzyme components
- How does HIV leave the cell? → Assembly at the cell membrane, then budding
⭐ Transmission ★★★
Source: AIDS patients and asymptomatic HIV carriers.
| Route | Detail |
|---|---|
| 1 · Sexual contact — homosexual or heterosexual | Accounts for 80% of all infections |
| 2 · Blood | Exposure to infected blood or blood products · sharing contaminated needles (intravenous drug users) |
| 3 · Mother to baby | VERTICAL transmission |
Route 3 is Unit 20 §2's vertical transmission — HIV appears there in the group causing congenital infection without malformation.
- Name the source of HIV infection. → AIDS patients and asymptomatic HIV carriers
- Name the three routes with their weight. → Sexual contact (80% of all infections) · blood, including blood products and shared needles · mother-to-baby vertical transmission
Pathogenesis ★★★
The whole of AIDS is one sentence: immunodeficiency, from the destruction of CD4⁺ T cells. The deck lists five mechanisms of that destruction.
- Damage to the cell membrane — the virus destroys the cell as a result of BUDDING
- Formation of large MULTINUCLEATED cells
- Specific cytotoxic T cells kill infected cells; also NK cells
- Viral replication inhibits the biosynthesis of host cells
- APOPTOSIS of CD4⁺ T cells
Ask why destroying one cell type produces such total immune collapse, and the answer is which cell it is.
The CD4⁺ helper T cell is the conductor of the immune system. It licenses B cells to make antibody, activates macrophages to kill intracellular organisms, and helps cytotoxic T cells mature. Remove it and every other arm fails too.
That is why the AIDS-defining illnesses in §6 are precisely the ones controlled by cell-mediated immunity: tuberculosis (Unit 13 — the granuloma needs CD4 cells), candida, Pneumocystis, and the reactivation of latent herpesviruses from Unit 25 — CMV retinitis, and Kaposi's sarcoma from HHV-8.
It also closes a loop with Unit 20 §4: viruses destroy immune cells — e.g. HIV destroys CD4⁺ T cells was listed there as a mechanism of persistent infection. The virus survives by disabling the response that would clear it.
And note mechanism 3: your own cytotoxic T cells kill infected CD4 cells. Immunopathogenesis again — part of the CD4 loss is self-inflicted.
- What is the pathogenesis of AIDS in one line? → Immunodeficiency from destruction of CD4⁺ T cells
- Name the five mechanisms of CD4 cell injury. → Membrane damage from budding · multinucleated cell formation · killing by specific cytotoxic T cells and NK cells · inhibition of host biosynthesis by viral replication · apoptosis
- Why does losing CD4 cells disable all immunity? → The CD4 helper cell coordinates antibody production, macrophage activation and cytotoxic T-cell maturation
⭐ Clinical features ★★★
Acquired immunodeficiency syndrome: the FINAL STAGE of HIV infection. People at this stage have badly damaged immune systems, which puts them at risk for opportunistic infections and tumours.
⭐ The four major categories
| Stage | Features |
|---|---|
| I · Acute infection (HIV seroconversion illness) | Extremely high HIV load — up to 10 million viruses per ml of blood. Mild symptoms: a flu-like illness with fever, large swollen lymph nodes, night sweats, skin rash and headache |
| II · Asymptomatic infection | Virus almost disappears from the blood, but persists in extravascular tissues — lymph node, dendritic cells — and continues to reproduce. Antibodies against both surface and internal proteins appear. No symptoms. The period may last 2–10 YEARS |
| III · Symptomatic infection — AIDS-related complex (ARC), with persistent generalised lymphadenopathy (PGL) | Massive loss of CD4⁺ cells. Severe symptoms: fever, night sweats, chronic diarrhoea, persistent generalised lymphadenopathy. HIV patients with high CD4⁺ counts do not develop AIDS |
| IV · Advanced disease — AIDS | CD4⁺ cells fall BELOW 200 per ml. Virus titre rises rapidly and the remaining immune response collapses. Opportunistic infections · cancer · death in about 2 years without intervention |
| Complication | Examples |
|---|---|
| Opportunistic infections | Tuberculosis (Mycobacterium) · candida glossitis |
| Cancer | Kaposi's sarcoma — human herpesvirus 8 |
| Neurological disease | AIDS dementia complex |
For the remaining marks:
• The defining number — CD4⁺ count falls below 200 per ml, the virus titre rises and the remaining immune response collapses.
• The consequences — opportunistic infections (tuberculosis, candidiasis), tumours (Kaposi's sarcoma, from HHV-8) and neurological disease (AIDS dementia complex).
• The outcome — death in about 2 years without intervention.
Do not stop at expanding the acronym — the four marks are for the mechanism, the CD4 threshold, and the opportunistic infections and tumours.
Clinical features — the four stages (4):
I · Acute infection — extremely high viral load (up to 10 million/ml), a mild flu-like illness with fever, lymphadenopathy, night sweats, rash and headache.
II · Asymptomatic infection — virus almost gone from blood but persisting and replicating in lymph nodes and dendritic cells; antibodies appear; lasts 2–10 years.
III · Symptomatic infection (ARC) — massive CD4⁺ loss, with fever, night sweats, chronic diarrhoea and persistent generalised lymphadenopathy.
IV · AIDS — CD4⁺ below 200/ml, opportunistic infections, cancer and neurological disease; death in about 2 years untreated.
Naming the 80%, the 2–10 years and the 200/ml is what lifts this from a list to a full-mark answer.
- Define AIDS. → Acquired immunodeficiency syndrome — the final stage of HIV infection, with a badly damaged immune system putting the patient at risk of opportunistic infections and tumours
- Name the four clinical categories. → Acute infection · asymptomatic infection · symptomatic infection (ARC/PGL) · AIDS
- What happens in acute infection? → Extremely high viral load up to 10 million/ml with a mild flu-like illness
- How long is the asymptomatic stage, and what is happening? → 2–10 years; virus almost gone from blood but replicating in lymph nodes and dendritic cells, with antibodies present
- What defines AIDS numerically? → CD4⁺ cells below 200 per ml
- Name the complications of AIDS. → Opportunistic infections (tuberculosis, candida glossitis), cancer (Kaposi's sarcoma from HHV-8), and AIDS dementia complex
Diagnosis, prevention and treatment ★★★
- Detection of antibody or antigen — ELISA
- Detection of nucleic acid — RT-PCR
- Virus isolation
Significance of the diagnosis
- Diagnosis of infection in an individual with or without symptoms
- Monitoring disease progression with or without antiviral therapy
- Screening blood and organ donors, voluntary screening of at-risk individuals, and seroepidemiologic surveys
- Evaluation of new antivirals or vaccines
| Detail | |
|---|---|
| Prevention | Health education · strict examination of blood and blood products · strict selection of blood donors |
| ⚠️ Vaccine | NOT AVAILABLE — because of the high mutation rate, and because latent infection and the formation of multinucleated cells result in immune escape |
| HAART | Highly Active Anti-Retroviral Therapy: TWO nucleoside analogue RT inhibitors plus ONE protease inhibitor |
| Drug class | Examples |
|---|---|
| Nucleoside reverse transcriptase inhibitors | AZT (azidothymidine) · ddI (dideoxyinosine) |
| Non-nucleoside reverse transcriptase inhibitors | Nevirapine |
| Protease inhibitors | Saquinavir · indinavir · ritonavir |
The deck is blunt about the limits: these drugs just control the progress of AIDS. Its closing slide: education led to a levelling off in the rate of increase in AIDS, and HAART has greatly slowed the death rate.
- How is HIV diagnosed? → Antibody or antigen detection by ELISA, nucleic acid detection by RT-PCR, and virus isolation
- Why is there no HIV vaccine? → The high mutation rate, and immune escape through latent infection and multinucleated cell formation
- What is HAART? → Highly active antiretroviral therapy — two nucleoside RT inhibitors plus one protease inhibitor
- Name the three drug classes with examples. → Nucleoside RT inhibitors (AZT, ddI), non-nucleoside RT inhibitors (nevirapine), protease inhibitors (saquinavir, indinavir, ritonavir)
HTLV ★★
| Detail | |
|---|---|
| Characteristics | Oncovirinae · spherical, ~100 nm · enveloped, with gp21 and gp46 · capsid proteins p24 and p15 |
| Transmission | Blood transfusion · sexual contact (HTLV-2 may be poorly transmitted sexually) · mother to child — by breastfeeding, with 20% of children of seropositive mothers acquiring the virus |
| HTLV-1 | Associated with 2 fatal human diseases: adult acute T-cell lymphocytic leukaemia (ATLL), and HTLV-associated myelopathy (HAM), also called tropical spastic paraparesis (TSP) |
| HTLV-2 | Hairy cell leukaemia; myelopathy |
- Describe HTLV. → Oncovirinae, spherical ~100 nm, enveloped with gp21 and gp46, capsid p24 and p15
- How is it transmitted? → Blood transfusion, sexual contact, and mother to child by breastfeeding — 20% of children of seropositive mothers
- Which diseases? → HTLV-1: adult T-cell lymphocytic leukaemia and HTLV-associated myelopathy (tropical spastic paraparesis). HTLV-2: hairy cell leukaemia and myelopathy
Revision
⭐ The 2019 comprehensive question (Section IV, 10 marks)
Then go deep on ONE. HIV is the strongest choice because the pathogenesis is a complete story: gp120 binds CD4 with the CCR5 or CXCR4 co-receptor → fusion and entry → reverse transcription to DNA → integration by integrase as a provirus → destruction of CD4⁺ T cells by budding damage, syncytium formation, CTL and NK killing, inhibition of host biosynthesis and apoptosis → progressive immunodeficiency through the four clinical stages → CD4 below 200/ml, opportunistic infection, tumour and death.
Note the shape of the question: list ≥N pathogens, then go deep on one. Both 2019 and 2020 use it, so expect it again whatever the topic.
The whole unit on one screen
| Question | Answer |
|---|---|
| Retrovirus? | Enveloped RNA virus replicating via a DNA intermediate |
| HIV structure? | 100 nm; gp120 and gp41 envelope; p24 capsid; diploid +ssRNA, RT and integrase |
| Genes? | env, pol, gag + 6 regulatory (tat, rev, nef, vif, vpr, vpu) |
| Receptor? | CD4, with co-receptor CCR5 or CXCR4 |
| Provirus? | Viral DNA integrated into host DNA by integrase |
| ⭐ Transmission? | Sexual (80%) · blood and needles · vertical |
| Pathogenesis? | Destruction of CD4⁺ T cells by 5 mechanisms |
| ⭐ Four stages? | Acute (viraemia 10⁷/ml) · asymptomatic (2–10 y) · ARC · AIDS (CD4 < 200/ml) |
| Complications? | TB, candida · Kaposi's sarcoma (HHV-8) · AIDS dementia |
| Vaccine? | None — high mutation rate and immune escape |
| HAART? | 2 nucleoside RT inhibitors + 1 protease inhibitor |
| HTLV-1? | Adult T-cell leukaemia and HTLV-associated myelopathy |
- Define AIDS for 4 marks. → The final stage of HIV infection, in which destruction of CD4⁺ T cells leaves the immune system badly damaged; CD4 falls below 200/ml, and the patient develops opportunistic infections, tumours such as Kaposi's sarcoma, and neurological disease, dying in about 2 years untreated
- Give the transmission routes and clinical features of HIV. → Sexual (80%), blood and needles, vertical; then acute infection with very high viral load, 2–10 years asymptomatic, ARC with massive CD4 loss, and AIDS below 200 CD4/ml
- Describe the HIV life cycle. → gp120 binds CD4 and CCR5/CXCR4 → fusion and internalisation → uncoating → reverse transcription to DNA → integration as provirus → transcription by host RNA polymerase II → translation and cleavage by viral protease → gp160 cleaved by furin → assembly at the membrane → budding
- Name the five mechanisms of CD4 cell injury. → Budding damage to the membrane · multinucleated cell formation · CTL and NK killing · inhibition of host biosynthesis · apoptosis
- Why is there no vaccine? → High mutation rate, and immune escape via latency and multinucleated cell formation